Clinical Trials Logo

Clinical Trial Summary

Hypothesis : Therapeutic intensification by increasing the dose delivered to the tumor by RCMI (conformational radiotherapy by intensity modulation) in order to reduce local relapse, often associated with poor prognosis

Primary objective: evaluate the rate of tumor sterilization and the toxicities of RTCT with concomitant boost in intensity modulation in patients with rectal cancer CT3-T4 and / or cN1-2.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03200249
Study type Interventional
Source Centre Georges Francois Leclerc
Contact
Status Completed
Phase N/A
Start date December 22, 2016
Completion date January 7, 2020